All In Biotech

Drug Trial Radar · NCT02767947

Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis

A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Product 33525 in Pediatric Subjects With Tinea Corporis

Last checked: Nov 20, 2026Latest source record: Nov 27, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

75

Actual

Start

Feb 8, 2016

Primary completion

Jun 29, 2016

Study completion Sep 22, 2016

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
May 11, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 2 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study was to evaluate the safety, efficacy, and pharmacokinetics of luliconazole cream 1% when applied topically for 7 days in pediatric participants 2 years to 17 years of age (inclusive) with tinea corporis.

Conditions

  • Tinea Corporis

Interventions

  • Luliconazole Cream 1%Drug

    Luliconazole cream will be applied per schedule specified in the arm.

  • Vehicle CreamDrug

    Vehicle cream will be applied per schedule specified in the arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Circulating Plasma Concentration of Luliconazole at Day 7 (Pre-Dose)Time frame: Pre-dose (within 15 minutes prior to the final dose of the drug) on Day 7
  2. Circulating Plasma Concentration of Luliconazole at Day 7 (6 Hours Post-Dose)Time frame: 6 hours after the final dose of the drug on Day 7

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Valeant Site 03

    San Cristobal, Dominican Republic

  • Valeant Site 01

    Santo Domingo, Dominican Republic

  • Valeant Site 02

    San Pedro Sula, Honduras

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.